Alkermes plc

Alkermes plcverified

ALKS

Price:

$24.01

Market Cap:

$4.01B

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relaps...[Read more]

Industry

Biotechnology

IPO Date

1991-07-16

Stock Exchange

NASDAQ

Ticker

ALKS

The PE Ratio as of April 2024 (TTM) for Alkermes plc (ALKS) is 7.85

According to Alkermes plc’s latest financial reports and current stock price. The company's current PE Ratio is 7.85. This represents a change of 132.14% compared to the average of 3.38 of the last 4 quarters.

Alkermes plc (ALKS) Historical PE Ratio (quarterly & annually)

How has ALKS PE Ratio performed in the past?

The mean historical PE Ratio of Alkermes plc over the last ten years is -59.79. The current 7.85 PE Ratio has changed -1412.92% with respect to the historical average. Over the past ten years (40 quarters), ALKS's PE Ratio was at its highest in in the December 2021 quarter at 1.08K. The PE Ratio was at its lowest in in the September 2020 quarter at -4917.27.

Quarterly (TTM)
Annual

Average

-59.79

Median

-36.62

Minimum

-283.00

Maximum

13.23

Alkermes plc (ALKS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alkermes plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 171.95%

Maximum Annual PE Ratio = 13.23

Minimum Annual Increase = -332.58%

Minimum Annual PE Ratio = -283.00

Quarterly (TTM)
Annual
YearPE RatioChange
202313.23-149.02%
2022-27.00-65.26%
2021-77.72171.95%
2020-28.5875.38%
2019-16.29-50.41%
2018-32.86-38.19%
2017-53.1631.61%
2016-40.39-22.53%
2015-52.14-81.58%
2014-283.00-332.58%

Alkermes plc (ALKS) Average PE Ratio

How has ALKS PE Ratio performed in the past?

The current PE Ratio of Alkermes plc (ALKS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-30.49

5-year avg

-27.27

10-year avg

-59.79

Alkermes plc (ALKS) PE Ratio vs. Peers

How is ALKS’s PE Ratio compared to its peers?

Alkermes plc’s PE Ratio is greater than Intra-Cellular Therapies, Inc. (-50.03), greater than Ironwood Pharmaceuticals, Inc. (-1.25), greater than Deciphera Pharmaceuticals, Inc. (-6.26), less than Pacira BioSciences, Inc. (28.27), less than ANI Pharmaceuticals, Inc. (65.37), less than Dr. Reddy's Laboratories Limited (19.66), less than Collegium Pharmaceutical, Inc. (24.01), greater than Eagle Pharmaceuticals, Inc. (3.05), less than Phibro Animal Health Corporation (33.96), greater than Prestige Consumer Healthcare Inc. (-42.86), less than Neurocrine Biosciences, Inc. (54.71), greater than Dynavax Technologies Corporation (-226.81), less than Amphastar Pharmaceuticals, Inc. (14.27), greater than Evolus, Inc. (-10.39),

Build a custom stock screener for Alkermes plc (ALKS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alkermes plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alkermes plc (ALKS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alkermes plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Alkermes plc's PE Ratio?

How is the PE Ratio calculated for Alkermes plc (ALKS)?

What is the highest PE Ratio for Alkermes plc (ALKS)?

What is the 3-year average PE Ratio for Alkermes plc (ALKS)?

What is the 5-year average PE Ratio for Alkermes plc (ALKS)?

How does the current PE Ratio for Alkermes plc (ALKS) compare to its historical average?